93 results
424B3
DNTH
Dianthus Therapeutics Inc
9 May 24
Prospectus supplement
4:27pm
shareholder in Zenas and serves as Chief Executive Officer and Chairman of the Board of Directors of Zenas and (ii) Fairmount Healthcare Fund LP … and Fairmount Healthcare Fund II LP (together, the “Fairmount Funds”), who are significant shareholders in the Company and have a seat on the Board
8-K
EX-99.1
DNTH
Dianthus Therapeutics Inc
9 May 24
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
4:08pm
Life Sciences, RA Capital Management, Avidity Partners, Fairmount, Venrock Healthcare Capital Partners, RTW Investments, Great Point Partners LLC
8-K
EX-99.1
u9qv62 5kod5w0l
21 Mar 24
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results
4:04pm
8-K
EX-10.2
cv12 7d06zg
22 Jan 24
Dianthus Therapeutics Announces $230 Million Private Placement
7:34am
8-K
EX-10.1
l14shh
22 Jan 24
Dianthus Therapeutics Announces $230 Million Private Placement
7:34am
8-K
EX-99.1
qr4zp5
22 Jan 24
Dianthus Therapeutics Announces $230 Million Private Placement
7:34am
8-K
cf6g4jyv vfa7yfj37
8 Jan 24
Results of Operations and Financial Condition
8:02am
8-K
EX-99.1
a5z1su8 j5yj8wlgn
9 Nov 23
Dianthus Therapeutics Highlights Recent Business Achievements and Third Quarter 2023 Financial Results
4:09pm
8-K/A
EX-99.2
ugw7xc3o sv0ar
20 Sep 23
Results of Operations and Financial Condition
9:50pm
8-K/A
EX-99.4
cmp5ne2p7uehsxx 820c
20 Sep 23
Results of Operations and Financial Condition
9:50pm
8-K/A
EX-99.1
ntj5xysdvm0h195c43
20 Sep 23
Results of Operations and Financial Condition
9:50pm
8-K
b5ugwj xece
12 Sep 23
Magenta Therapeutics Announces Completion of Merger with Dianthus Therapeutics and Implementation of Reverse Stock Split
4:05pm